Media Gets Sneak Peek at Annual Meeting Scientific Presentations
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Tag: immunotherapy
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Immune-related adverse events (irAEs) is the collective term used to describe the side effects that arise in response to...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Treatment with checkpoint inhibitors is often billed as gentler than chemotherapy—and it is true that immunotherapy doesn’t come with...